PMID: 6992131Jan 1, 1980Paper

Effect of bromocriptine on maturity onset diabetes

Postgraduate Medical Journal
Anthony H BarnettC J Hayter

Abstract

The effect of the dopamine agonist, bromocriptine, and the dopamine antagonist, metoclopramide, on glucose tolerance was examined in maturity onset diabetics and normal subjects. After bromocriptine there was a lowered fasting blood glucose and improved glucose tolerance in the diabetics. The controls showed an initial improvement in glucose tolerance. A reduction in insulin levels and a marked fall in plasma prolactin was observed in all subjects. Growth hormone concentrations were low and unaffected in the diabetics, and there was an inconsistent rise in the normals. After metoclopramide there was some impairment in glucose tolerance in the normal subjects, but this was not significant in the diabetics. There was also a marked prolactin release in all subjects, but no significant effect on insulin or growth hormone. It is concluded that bromocriptine lowers the blood glucose and improves glucose tolerance in maturity onset diabetics. This action may be the result of the lowered prolactin which occurred without a concomitant rise in growth hormone.

References

Feb 28, 1976·Lancet·G Teasdale
Apr 1, 1977·Diabetologia·R LandgrafP C Scriba
Sep 1, 1977·The Journal of Clinical Endocrinology and Metabolism·P D WoolfR Campbell
Feb 8, 1975·British Medical Journal·M O ThornerG M Besser
Mar 1, 1975·The Journal of Clinical Endocrinology and Metabolism·F CamanniG M Molinatti
Nov 1, 1972·The Journal of Clinical Endocrinology and Metabolism·E Del PozoH Friesen
Sep 1, 1973·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M RozencweigC Robyn

❮ Previous
Next ❯

Citations

Oct 11, 2011·Cardiology in Review·Guy Valiquette
Oct 28, 2010·Diabetes, Obesity & Metabolism·R I G HoltC J Bailey
Jan 10, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Felicitas Lopez VicchiDamasia Becu-Villalobos
Jun 28, 2011·Lancet·Abd A TahraniAnthony H Barnett
May 20, 2014·Journal of Diabetes and Its Complications·Tance SonnierCourtney M Peterson
Jun 25, 2016·Nature Reviews. Endocrinology·Abd A TahraniClifford J Bailey
Oct 28, 2010·The Annals of Pharmacotherapy·Jessica L KerrKatherine A Petkewicz
Jan 1, 1985·Postgraduate Medical Journal·A D MooradianR B Shafer
Feb 25, 1985·Life Sciences·H F MohamedI el-Wakkad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.